http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104327055-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4196 |
| filingDate | 2014-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104327055-B |
| titleOfInvention | 1-(benzofuran-5-base)-2-(1,2,4-triazol-1-yl) ketoxime ether-acylamide and preparation method and application |
| abstract | The present invention relates to 1 (benzofuran 5 base) 2 (1,2,4 triazole 1 base) ketoxime ether-acylamide or its salt shown in chemical constitution formula I: Wherein, R is selected from hydrogen, deuterium, C 1 ～C 2 Alkyl, C 3 ～C 4 Straight or branched alkyl, hydroxyl, C 1 ～C 2 Alkoxyl, C 3 ～C 4 Unbranched alkoxy or branched alkoxy；R 1 、R 2 It is selected from: hydrogen, deuterium, C 1 ～C 2 Alkyl, C 3 ～C 4 Straight or branched alkyl；N is selected from: 0,1；X 1 、X 5 It is selected from: hydrogen, deuterium, C 1 ～C 2 Alkyl, C 3 ～C 4 Straight chained alkyl or branched alkyl；X 2 、X 4 It is selected from: hydrogen, deuterium, C 1 ～C 2 Alkyl, C 3 ～C 4 Straight chained alkyl or branched alkyl；X 3 It is selected from: hydrogen, deuterium, C 1 ～C 2 Alkyl, C 3 ～C 4 Straight chained alkyl or branched alkyl, C 1 ～C 2 Alkoxyl, C 3 ～C 4 Unbranched alkoxy or branched alkoxy, fluorine, chlorine, bromine or iodine；1 (benzofuran 5 base) 2 (1,2,4 triazole 1 base) ketoxime ether-acylamide or application in preparing cancer therapy drug of its salt. |
| priorityDate | 2014-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 86.